DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Fermenta Biotech Limited — Board Meeting Intimation

NSE 3 hrs ago·4 Aug 2026, 12:16 pm

Fermenta Biotech

Fermenta Biotech has announced that its board will meet on August 11, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a routine corporate action that signals the management's commitment to transparency and timely disclosure of performance data.

For investors, this announcement is significant as it provides a crucial update on the company's operational health. The results will offer insights into Fermenta's revenue growth, profitability, and cash flow during the first half of the fiscal year. Investors should pay close attention to the guidance provided by the management during the post-result interaction to understand future expectations.